Related Experiment Video
Updated: Mar 10, 2026
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Nebulized epinephrine for young children with bronchiolitis
Insights
Nebulized epinephrine is not routinely recommended for infants with bronchiolitis. It may be considered for severe cases, but further doses are discouraged if there
Area of Science:
- Pediatrics
- Respiratory Medicine
Background:
- Infants often present with flulike symptoms and wheezing during winter months.
- Bronchiolitis is a common diagnosis in infants with these symptoms.
Purpose of the Study:
- To determine the prudence of emergency department treatment with nebulized epinephrine for infants diagnosed with bronchiolitis.
Main Methods:
- The study evaluated the use of nebulized epinephrine in infants presenting with bronchiolitis symptoms.
Main Results:
- Nebulized epinephrine is not advised for routine use in infants with bronchiolitis.
- It can be considered for infants with severe symptoms.
Conclusions:
- Further doses of nebulized epinephrine are not recommended if initial treatment shows no improvement.
- Additional research is needed on combining epinephrine with agents like hypertonic saline or oral dexamethasone.
Question:
Every winter I see infants with flulike symptoms and wheezing. I frequently diagnose them with bronchiolitis based on their presenting symptoms. Would it be prudent to send those infants to the nearest emergency department for treatment with nebulized epinephrine?
Answer:
Nebulized epinephrine should not be routinely used in infants with bronchiolitis. It is an option to consider in those with severe symptoms. If it is given and there are no signs of improvement, further doses are discouraged. Ongoing studies of epinephrine combined with other agents (eg, hypertonic saline, oral dexamethasone) are needed to confirm their benefit.
Related Concept Videos
01:23Inhaled Medications
01:30Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...